UBS AM’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $893K | Buy |
|
|||||
|
2025
Q2 | $99.4K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $130K | Hold |
|
|||||
|
2021
Q4 | $409K | Buy |
|
|||||
|
2021
Q3 | $502K | Sell |
|
|||||
|
2021
Q2 | $753K | Buy |
|
|||||
|
2021
Q1 | $316K | Buy |
|
|||||
|
2020
Q4 | $247K | Hold |
|
|||||
|
2020
Q3 | $221K | Sell |
|
|||||
|
2020
Q2 | $1.21M | Buy |
|
|||||
|
2020
Q1 | $600K | Sell |
|
|||||
|
2019
Q4 | $528K | Buy |
|
|||||
|
2019
Q3 | $315K | Buy |
|
|||||
|
2019
Q2 | $362K | Buy |
|
|||||
|
2019
Q1 | $520K | Buy |
|
|||||
|
2018
Q4 | $225K | Buy |
|
|||||
|
2018
Q3 | $157K | Hold |
|
|||||
|
2018
Q2 | $178K | Hold |
|
|||||
|
2018
Q1 | $170K | Buy |
|